vs

Side-by-side financial comparison of Shift4 Payments, Inc. (FOUR) and Royalty Pharma plc (RPRX). Click either name above to swap in a different company.

Shift4 Payments, Inc. is the larger business by last-quarter revenue ($1.2B vs $622.0M, roughly 1.9× Royalty Pharma plc). Royalty Pharma plc runs the higher net margin — 34.4% vs 3.4%, a 31.1% gap on every dollar of revenue. On growth, Shift4 Payments, Inc. posted the faster year-over-year revenue change (34.0% vs 4.8%). Over the past eight quarters, Shift4 Payments, Inc.'s revenue compounded faster (29.6% CAGR vs 4.6%).

Shift4 Payments, Inc. is an American payment processing company based in Allentown, Pennsylvania. The company, founded in 1999 by the then 16-year-old Jared Isaacman, processes payments for over 200,000 businesses in the retail, hospitality, leisure, and restaurant industries. Shift4 specializes in commerce technology such as mobile payment software and hardware. The company was publicly listed on the New York Stock Exchange in 2020.

Acceleron Pharma, Inc. is an American clinical stage biopharmaceutical company based in Cambridge, Massachusetts with a broad focus on developing medicines that regulate the transforming growth factor beta (TGF-β) superfamily of proteins, which play fundamental roles in the growth and repair of cells and tissues such as red blood cells, muscle, bone, and blood vessels.

FOUR vs RPRX — Head-to-Head

Bigger by revenue
FOUR
FOUR
1.9× larger
FOUR
$1.2B
$622.0M
RPRX
Growing faster (revenue YoY)
FOUR
FOUR
+29.2% gap
FOUR
34.0%
4.8%
RPRX
Higher net margin
RPRX
RPRX
31.1% more per $
RPRX
34.4%
3.4%
FOUR
Faster 2-yr revenue CAGR
FOUR
FOUR
Annualised
FOUR
29.6%
4.6%
RPRX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
FOUR
FOUR
RPRX
RPRX
Revenue
$1.2B
$622.0M
Net Profit
$40.2M
$214.2M
Gross Margin
Operating Margin
10.8%
62.4%
Net Margin
3.4%
34.4%
Revenue YoY
34.0%
4.8%
Net Profit YoY
-65.3%
2.9%
EPS (diluted)
$0.49

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
FOUR
FOUR
RPRX
RPRX
Q4 25
$1.2B
$622.0M
Q3 25
$1.2B
$609.3M
Q2 25
$966.2M
$578.7M
Q1 25
$848.3M
$568.2M
Q4 24
$887.0M
$593.6M
Q3 24
$909.2M
$564.7M
Q2 24
$827.0M
$537.3M
Q1 24
$707.4M
$568.0M
Net Profit
FOUR
FOUR
RPRX
RPRX
Q4 25
$40.2M
$214.2M
Q3 25
$28.1M
$288.2M
Q2 25
$34.0M
$30.2M
Q1 25
$16.7M
$238.3M
Q4 24
$116.0M
$208.2M
Q3 24
$53.8M
$544.0M
Q2 24
$39.2M
$102.0M
Q1 24
$20.6M
$4.8M
Operating Margin
FOUR
FOUR
RPRX
RPRX
Q4 25
10.8%
62.4%
Q3 25
9.7%
70.1%
Q2 25
8.6%
36.3%
Q1 25
3.0%
94.0%
Q4 24
9.7%
60.9%
Q3 24
8.8%
Q2 24
7.2%
50.2%
Q1 24
3.0%
-13.0%
Net Margin
FOUR
FOUR
RPRX
RPRX
Q4 25
3.4%
34.4%
Q3 25
2.4%
47.3%
Q2 25
3.5%
5.2%
Q1 25
2.0%
41.9%
Q4 24
13.1%
35.1%
Q3 24
5.9%
96.3%
Q2 24
4.7%
19.0%
Q1 24
2.9%
0.8%
EPS (diluted)
FOUR
FOUR
RPRX
RPRX
Q4 25
$0.49
Q3 25
$0.67
Q2 25
$0.07
Q1 25
$0.55
Q4 24
$0.46
Q3 24
$1.21
Q2 24
$0.23
Q1 24
$0.01

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
FOUR
FOUR
RPRX
RPRX
Cash + ST InvestmentsLiquidity on hand
$964.0M
$618.7M
Total DebtLower is stronger
$4.5B
$9.0B
Stockholders' EquityBook value
$1.4B
$9.7B
Total Assets
$8.7B
$19.6B
Debt / EquityLower = less leverage
3.15×
0.92×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
FOUR
FOUR
RPRX
RPRX
Q4 25
$964.0M
$618.7M
Q3 25
$1.5B
$938.9M
Q2 25
$3.0B
$631.9M
Q1 25
$1.2B
$1.1B
Q4 24
$1.2B
$929.0M
Q3 24
$1.4B
$950.1M
Q2 24
$205.0M
$1.8B
Q1 24
$522.9M
$843.0M
Total Debt
FOUR
FOUR
RPRX
RPRX
Q4 25
$4.5B
$9.0B
Q3 25
$4.7B
$8.9B
Q2 25
$3.7B
$8.0B
Q1 25
$2.8B
$7.6B
Q4 24
$2.8B
$7.6B
Q3 24
$7.6B
Q2 24
$7.6B
Q1 24
$6.1B
Stockholders' Equity
FOUR
FOUR
RPRX
RPRX
Q4 25
$1.4B
$9.7B
Q3 25
$1.7B
$9.6B
Q2 25
$1.6B
$9.5B
Q1 25
$805.2M
$9.8B
Q4 24
$806.6M
$10.3B
Q3 24
$811.8M
$10.3B
Q2 24
$700.8M
$9.8B
Q1 24
$674.5M
$9.9B
Total Assets
FOUR
FOUR
RPRX
RPRX
Q4 25
$8.7B
$19.6B
Q3 25
$9.0B
$19.3B
Q2 25
$7.0B
$18.3B
Q1 25
$5.0B
$17.6B
Q4 24
$5.0B
$18.2B
Q3 24
$5.0B
$18.0B
Q2 24
$3.5B
$17.7B
Q1 24
$3.4B
$16.1B
Debt / Equity
FOUR
FOUR
RPRX
RPRX
Q4 25
3.15×
0.92×
Q3 25
2.83×
0.93×
Q2 25
2.34×
0.84×
Q1 25
3.53×
0.78×
Q4 24
3.52×
0.74×
Q3 24
0.74×
Q2 24
0.78×
Q1 24
0.62×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
FOUR
FOUR
RPRX
RPRX
Operating Cash FlowLast quarter
$223.7M
$827.1M
Free Cash FlowOCF − Capex
$222.5M
FCF MarginFCF / Revenue
18.7%
Capex IntensityCapex / Revenue
0.1%
Cash ConversionOCF / Net Profit
5.56×
3.86×
TTM Free Cash FlowTrailing 4 quarters
$624.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
FOUR
FOUR
RPRX
RPRX
Q4 25
$223.7M
$827.1M
Q3 25
$171.8M
$702.6M
Q2 25
$141.9M
$364.0M
Q1 25
$96.6M
$596.1M
Q4 24
$145.4M
$742.5M
Q3 24
$182.1M
$703.6M
Q2 24
$116.1M
$658.2M
Q1 24
$56.7M
$664.6M
Free Cash Flow
FOUR
FOUR
RPRX
RPRX
Q4 25
$222.5M
Q3 25
$165.4M
Q2 25
$141.0M
Q1 25
$95.1M
Q4 24
$143.8M
Q3 24
$180.1M
Q2 24
$113.9M
Q1 24
$55.4M
FCF Margin
FOUR
FOUR
RPRX
RPRX
Q4 25
18.7%
Q3 25
14.1%
Q2 25
14.6%
Q1 25
11.2%
Q4 24
16.2%
Q3 24
19.8%
Q2 24
13.8%
Q1 24
7.8%
Capex Intensity
FOUR
FOUR
RPRX
RPRX
Q4 25
0.1%
Q3 25
0.5%
Q2 25
0.1%
Q1 25
0.2%
Q4 24
0.2%
Q3 24
0.2%
Q2 24
0.3%
Q1 24
0.2%
Cash Conversion
FOUR
FOUR
RPRX
RPRX
Q4 25
5.56×
3.86×
Q3 25
6.11×
2.44×
Q2 25
4.17×
12.06×
Q1 25
5.78×
2.50×
Q4 24
1.25×
3.57×
Q3 24
3.38×
1.29×
Q2 24
2.96×
6.45×
Q1 24
2.75×
139.10×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

FOUR
FOUR

Payments Based Revenue$788.8M66%
Other$255.0M21%
Subscription And Other Revenues$144.8M12%

RPRX
RPRX

Financial Royalty Assets$592.4M95%
Royalty Income Other$29.6M5%

Related Comparisons